Open Access

How-To manage HFpEF: state of the art in 2021

Event: ESC Congress 2021 - The Digital Experience
Topic: Chronic Heart Failure
Session type: Symposium
Date: 28 August 2021
Time: 09:30 - 10:15

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

5 presentations in this session

HFpEF management: state of the art neurohumoral modulation.

Speaker: Professor S. Solomon (Boston, US)
Thumbnail

HFpEF management: state of the art SGLT2 inhibitors.

Speaker: Professor R. De Boer (Groningen, NL)
Thumbnail

HFpEF management: state of the art novel devices.

Speaker: Professor D. Kaye (Melbourne, AU)
Thumbnail

How-To manage HFpEF: state of the art in 2021 – discussion.

Thumbnail

How-To manage HFpEF: state of the art in 2021 - Chat Moderator.

Thumbnail

3 speakers from this session

Professor Scott Solomon

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
42 presentations
0 follower

Professor Rudolf De Boer

University Medical Centre Groningen, Groningen (Netherlands (The))
41 presentations
0 follower

Professor David Kaye

The Alfred Hospital, Melbourne (Australia)
2 presentations
0 follower

Related content

Open Access

Trials Focus: GUIDE-HF / EMPEROR-Preserved

3 December 2021

Open Access

Current controversies in antithrombotic therapy

3 December 2021

Open Access

Opening session

2 December 2021

This platform is supported by

logo Novo Nordisk